Target intelligence / Profile preview

Nephrin protein (Nephrin)

Target
Nephrin
Molecular classification
Cell adhesion molecule, Immunoglobulin superfamily protein, Transmembrane protein
01

Overview

Nephrin protein is a large transmembrane cell adhesion molecule expressed predominantly on the surface of podocytes in the glomeruli of the kidney. It forms a crucial part of the slit diaphragm, a specialized junction that functions as both a physical and signaling barrier, preventing leakage of plasma proteins into urine and maintaining kidney filtration selectivity. Nephrin consists of multiple extracellular immunoglobulin-like domains and a cytoplasmic tail with conserved tyrosine residues that interact with scaffolding and signaling proteins, such as MAGI1 and Nck, to regulate podocyte structure and signaling. Mutations in the NPHS1 gene encoding nephrin disrupt its structural integrity or signaling function, resulting in congenital nephrotic syndrome (especially the Finnish type) and other severe proteinuric kidney diseases. Research continues into how nephrin's assembly at the slit diaphragm underpins renal health and how experimental agents may modify nephrin-related signaling in disease models.

Other names
NephrinNPHS1 protein
02

Mechanism of action

Not applicable for approved drugs; experimental mechanism includes blocking nephrin/MAGI1 signaling complex in the slit diaphragm

03

Biological functions

Structural component of slit diaphragm in glomerular filtration barrierCell adhesionSignal transduction (podocyte signaling and cytoskeletal organization)
04

Disease associations

Congenital nephrotic syndrome (Finnish type, due to NPHS1 mutation)Proteinuria (loss of barrier function, characteristic of a range of nephrotic syndromes)Other genetic and acquired kidney diseases involving podocyte dysfunction
05

Safety considerations

Loss or dysfunction of nephrin disrupts the filtration barrier, resulting in massive proteinuria, renal failure, and congenital nephrotic syndromes that are resistant to conventional therapy
06

Interacting drugs

None currently approved or highly characterized as direct nephrin modulators; some experimental peptides can disrupt nephrin-protein interactions
07

Biomarkers

NPHS1 gene mutations and nephrin protein levels are biomarkers for congenital nephrotic syndrome and podocyte injury

Beyond the preview

Go deeper on Nephrin protein (Nephrin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephrin protein (Nephrin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call